复星医药 (600196.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

22.3x

EV/EBITDA

10.5x

Market Cap

CNY 60.86B

MomentumView details →

1D Return

−3.27%

YTD Return

−15.67%

RSI (14)

40.7

ValuationView details →

P/E (Fwd)

22.3x

EV/EBITDA

10.5x

Market Cap

CNY 60.86B

RSI (14)

40.7

MomentumView details →

1D Return

−3.27%

YTD Return

−15.67%

ProfitabilityView details →

Gross Margin

50.50%

Net Margin

8.22%

EBITDA Margin

20.29%

ROE (TTM)

7.07%

ROA (TTM)

2.83%

Asset Turnover

0.35x

GrowthView details →

Revenue YoY

+4.92%

EPS YoY

+19.26%

FCF YoY

+159.50%

Revenue CAGR 3Y

−1.77%

EPS CAGR 3Y

−3.88%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.32

EPS Surprise

−11.12%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.35

Avg Surprise (4Q)

−11.12%

Rev Surprise

−4.11%

Capital & dividendView details →

Debt/Equity

0.60x

Current Ratio

0.93x

Quick Ratio

0.76x

Div Yield

1.75%

Div Rate

CNY 0.39

Div Growth 1Y

+21.88%

Financials snapshotView financials →

Revenue (TTM)

42.31B

Net Income (TTM)

3.48B

Op. CF (TTM)

5.31B

Next earningsNov 3, 2026 →

Latest newsMore news →

Fosun High Technology, the controlling shareholder of Fosun Pharma, pledged 330 million A-shares to ICBC Shanghai Changning Sub-branch on September 3, 2026, to secure debt repayment.11h ago

Fosun Pharma launched a block deal to divest 5% equity in Gland Pharma worth Rs 2,279 crore at a floor price of Rs 2,763 per share.1d ago

Similar companies

Takeda Pharmaceutical Company LimitedTAK Yuyu Pharma, Inc.000220.KS Yuyu Pharma, Inc.000225.KS Kukje Pharma Co., Ltd.002720.KS Ildong Holdings Co., Ltd.000230.KS Huons Global Co., Ltd.084110.KQ Find similar companies →

Latest newsMore news →

Fosun High Technology, the controlling shareholder of Fosun Pharma, pledged 330 million A-shares to ICBC Shanghai Changning Sub-branch on September 3, 2026, to secure debt repayment.11h ago Fosun Pharma launched a block deal to divest 5% equity in Gland Pharma worth Rs 2,279 crore at a floor price of Rs 2,763 per share.1d ago Fosun Pharma's controlling shareholder Fosun High Technology released a pledge on 69 million A-shares on July 21, 2026, and disclosed a subsequent pledge plan.44d ago